Publications by authors named "Harry Agress"

Claim this Profile
R
Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma.
Anthony Mato, Tatyana Feldman, Tania Zielonka, Arun Singavi, Gabriella Gadaletta, Harry Agress

Leuk Lymphoma· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.
Anthony R Mato, Jakub Svoboda, Tatyana Feldman, Tania Zielonka, Harry Agress

Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation and reporting of positron emission tomography-computed tomographic scans.
Harry Agress, Terence Z Wong, Paul Shreve

Semin Ultrasound CT MR· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.
Harry Agress, Benjamin Z Cooper

Radiology· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical role of FDG PET in evaluation of cancer patients.
Lale Kostakoglu, Harry Agress, Stanley J Goldsmith

Radiographics· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonic adenomas detected by F-FDG PET.
David M Felig, Ali Sedarat, Harry Agress, Stanley E Waintraub

Gastrointest Endosc· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis